Pulmonary Fibrosis clinical trials
20 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
- Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- Nucleoside Therapy in Patients With Telomere Biology Disorders
- Advanced Imaging for Pulmonary Fibrosis
- Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients
- FAPI PET for Lung Fibrosis
- Explanted Lung Tissues With Pulmonary Fibrosis
- Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
- Pulmonary Fibrosis Foundation Community Registry
- Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
- Role of Genetic Factors in the Development of Lung Disease
- SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
- Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
- Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis Patients
- Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring
- Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
- Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs
- A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
- Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Pulmonary Fibrosis” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.